Fintel reports that on October 3, 2025, D. Boral Capital maintained coverage of UroGen Pharma (NasdaqGM:URGN) with a Buy ...

The initiative, backed by a total financial outlay of Rs 5,000 Crore (nearly $600 million) spanning from FY 2023-24 to FY ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

India’s ₹5,000-cr plan opens applications to fund pharma and medtech R&D, helping firms move beyond low-cost generics toward ...